Todd Golub

Todd Golub

Harvard University

H-index: 186

North America-United States

About Todd Golub

Todd Golub, With an exceptional h-index of 186 and a recent h-index of 125 (since 2020), a distinguished researcher at Harvard University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract GS03-09: Characterization and proposed therapeutic exploitation of fusion RNAs in metastatic breast cancers

Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies

Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma

Abstract LB_A01: Rapidly cleared MCL1 inhibitor TTX-810 showing robust efficacy in preclinical tumor models with no effects on cardiomyocytes in vitro and in vivo

A nanoparticle priming agent reduces cellular uptake of cell-free DNA and enhances the sensitivity of liquid biopsies

Genome-Scale High-Resolution Spatial Mapping of the Pro-Tumorigenic Cellular Niche in Classic Hodgkin Lymphoma

An intravenous DNA-binding priming agent protects cell-free DNA and improves the sensitivity of liquid biopsies

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

Todd Golub Information

University

Position

Broad Institute

Citations(all)

278067

Citations(since 2020)

108268

Cited By

211320

hIndex(all)

186

hIndex(since 2020)

125

i10Index(all)

352

i10Index(since 2020)

293

Email

University Profile Page

Google Scholar

Top articles of Todd Golub

Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies

Science

2024/1/19

Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma

Molecular Cell

2024/1/18

Abstract LB_A01: Rapidly cleared MCL1 inhibitor TTX-810 showing robust efficacy in preclinical tumor models with no effects on cardiomyocytes in vitro and in vivo

Molecular Cancer Therapeutics

2023/12/1

A nanoparticle priming agent reduces cellular uptake of cell-free DNA and enhances the sensitivity of liquid biopsies

bioRxiv

2023/1/14

An intravenous DNA-binding priming agent protects cell-free DNA and improves the sensitivity of liquid biopsies

bioRxiv

2023/1/14

The Metastatic Breast Cancer Project: leveraging patient-partnered research to expand the clinical and genomic landscape of metastatic breast cancer and accelerate discoveries

medRxiv

2023

Abstract PR007: A liposomal priming agent increases the sensitivity of liquid biopsies

Cancer Prevention Research

2023/1/1

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Annals of Oncology

2023/10/1

Therapeutic targeting of phosphate dysregulation in cancer via the xpr1: kidins220 protein complex

2023/9/7

FDX1 regulates cellular protein lipoylation through direct binding to LIAS

Journal of Biological Chemistry

2023/9/1

Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal

Genome Biology

2023/8/23

MDB-32. TRANSLATION OF NON-CANONICAL OPEN READING FRAMES AS A CANCER CELL SURVIVAL MECHANISM IN CHILDHOOD MEDULLOBLASTOMA

Neuro-Oncology

2023/6

Methods and compositions for identifying and treating glutaminase inhibitor-sensitive cancers

2023/5/18

Single duplex DNA sequencing with CODEC detects mutations with high sensitivity

Nature Genetics

2023/5

Compounds and methods useful for treating or preventing cancers

2022/1/20

Methods of treating cancer

2018/12/18

See List of Professors in Todd Golub University(Harvard University)